Related references
Note: Only part of the references are listed.Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Ron C. Hoogeveen et al.
CLINICAL CHEMISTRY (2021)
Lipoprotein(a) and Cardiovascular Disease
Pia R. Kamstrup
CLINICAL CHEMISTRY (2021)
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)
Santica M. Marcovina et al.
CLINICAL CHEMISTRY (2021)
Novel method for quantification of lipoprotein (a)-cholesterol: implications for improving accuracy of LDL-C measurements
Calvin Yeang et al.
JOURNAL OF LIPID RESEARCH (2021)
Society Guidelines 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J. Pearson et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
Camilla Ditlev Lindhardt Johannesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
Johanna F. Schachtl-Riess et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Gregory G. Schwartz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank
Aniruddh P. Patel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels-Brief Report
Mary Hoekstra et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly
Mikael Croyal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Borge G. Nordestgaard et al.
ATHEROSCLEROSIS (2020)
ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis
Romain Capoulade et al.
HEART (2020)
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
A. Vuorio et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera A. Bittner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Sotirios Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
Johan G. Schnitzler et al.
CIRCULATION RESEARCH (2020)
Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
Lotte C. A. Stiekema et al.
EUROPEAN HEART JOURNAL (2020)
New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
Viraj Raygor et al.
CURRENT CARDIOLOGY REPORTS (2020)
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Devinder S. Dhindsa et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
Anurag Mehta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia
Sergei N. Pokrovsky et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Michael Szarek et al.
EUROPEAN HEART JOURNAL (2020)
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
Byambaa Enkhmaa et al.
NUTRIENTS (2020)
Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups
Minhal Makshood et al.
ATHEROSCLEROSIS (2020)
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
Michael Szarek et al.
EUROPEAN HEART JOURNAL (2020)
Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis
Brian T. Steffen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett et al.
CIRCULATION (2019)
New Frontiers in Lp(a)-Targeted Therapies
Matthew J. Borrelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Don P. Wilson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
Kang H. Zheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines
Scott M. Grundy et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families[S]
Byambaa Enkhmaa et al.
JOURNAL OF LIPID RESEARCH (2019)
Elevated Lipoprotein(a) and Risk of Ischemic Stroke
Anne Langsted et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis[S]
Michael B. Boffa et al.
JOURNAL OF LIPID RESEARCH (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial
Michelle L. O'Donoghue et al.
CIRCULATION (2019)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology
Donald M. Lloyd-Jones et al.
CIRCULATION (2019)
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
Guillaume Pare et al.
CIRCULATION (2019)
HEART UK consensus statement on Lipoprotein(a): A call to action
Jaimini Cegla et al.
ATHEROSCLEROSIS (2019)
High lipoprotein(a) and high risk of mortality
Anne Langsted et al.
EUROPEAN HEART JOURNAL (2019)
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
Michael B. Boffa et al.
NATURE REVIEWS CARDIOLOGY (2019)
Lipoprotein(a) catabolism: a case of multiple receptors
Sally P. A. McCormick et al.
PATHOLOGY (2019)
Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)RX and IONIS-APO(a)-LRX antisense oligonucleotide clinical trials
Santica M. Marcovina et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Relationship of lipoprotein(a) molar concentrations and mass according to lipoprotein(a) thresholds and apolipoprotein(a) isoform size
Sotirios Tsimikas et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein (a): a historical appraisal
Karam M. Kostner et al.
JOURNAL OF LIPID RESEARCH (2017)
The metabolism of lipoprotein (a): an ever-evolving story
Gissette Reyes-Soffer et al.
JOURNAL OF LIPID RESEARCH (2017)
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
Salome Mack et al.
JOURNAL OF LIPID RESEARCH (2017)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Lipoprotein (a) measurements for clinical application
Santica M. Marcovina et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Michael B. Boffa et al.
JOURNAL OF LIPID RESEARCH (2016)
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
Byambaa Enkhmaa et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein apheresis to treat elevated lipoprotein (a)
Elisa Waldmann et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Structure, function, and genetics of lipoprotein (a)
Konrad Schmidt et al.
JOURNAL OF LIPID RESEARCH (2016)
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
Connor A. Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Innate sensing of oxidation-specific epitopes in health and disease
Christoph J. Binder et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Romain Capoulade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort
Benoit J. Arsenault et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes The AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglyceride and Impact on Global Health Outcomes)
John J. Albers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
Jane Hoover-Plow et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Genetic Associations with Valvular Calcification and Aortic Stenosis
George Thanassoulis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
Anna Helgadottir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Lipoprotein(a), Inflammation, and Peripheral Arterial Disease in a Community-Based Sample of Older Men and Women (the InCHIANTI Study)
Stefano Volpato et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Review: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease
Srdjan Djurovic et al.
CLINICAL GENETICS (2010)
Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease
Kåre Berg et al.
CLINICAL GENETICS (2010)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lipoprotein(a) levels and risk of future coronary heart disease
Anna Bennet et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Lipoprotein (a) in patients with spontaneous venous thromboembolism
Rainer Vormittag et al.
THROMBOSIS RESEARCH (2007)
Catalysis of covalent Lp(a) assembly: Evidence for an extracellular enzyme activity that enhances disulfide bond formation
Lev Becker et al.
BIOCHEMISTRY (2006)
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
ML Koschinsky et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
R Marcucci et al.
AMERICAN JOURNAL OF MEDICINE (2003)
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
AA Kroon et al.
ATHEROSCLEROSIS (2000)
Apolipoprotein (a) fragments in relation to human carotid plaque instability
JE Fortunato et al.
JOURNAL OF VASCULAR SURGERY (2000)
Share Paper
